help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woodworth, C. D.
Right arrow Articles by Simpson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woodworth, C. D.
Right arrow Articles by Simpson, S.

American Journal of Pathology, Vol 142, 1544-1555, Copyright © 1993 by American Society for Investigative Pathology


REGULAR ARTICLES

Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines

CD Woodworth and S Simpson
National Cancer Institute, Laboratory of Biology, Bethesda, MD 20892.

The pathogenesis of cervical human papillomavirus (HPV) infection is influenced by the host's immune response. This response depends upon secretion of specific lymphokines to recruit and activate immune cells at the site of infection. To examine whether cervical cells enhance immune-responsiveness, secretion of lymphokines by cultures of normal cervical cells, HPV-immortalized cervical lines, and carcinoma lines was compared. Normal cervical cells constitutively secreted interleukin- 1 alpha (IL-1 alpha), IL-1 beta, IL-1 receptor antagonist, IL-6, IL-8, tumor necrosis factor-alpha, and granulocyte macrophage colony stimulating factor. Lymphokines were also produced by exo- and endocervical epithelia in vivo. In contrast, four cervical cell lines immortalized by HPV DNAs and three carcinoma lines secreted selected lymphokines at significantly reduced levels. Interferon-gamma induced major histocompatibility class I and II proteins and intercellular adhesion molecule-I in normal cells, but results in immortal or carcinoma lines were variable. These results suggest that cervical epithelial cells have the potential to influence inflammation and immunity in the cervical mucosa. Furthermore, decreased expression of lymphokines and histocompatibility molecules by HPV-immortalized cervical cells suggests that similar alterations might accompany persistent HPV infections in vivo.


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
D. J. Sharkey, A. M. Macpherson, K. P. Tremellen, and S. A. Robertson
Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells
Mol. Hum. Reprod., July 1, 2007; 13(7): 491 - 501.
[Abstract] [Full Text] [PDF]


Home page
Adv. Dent. Res.Home page
J. Palefsky
Biology of HPV in HIV Infection
Adv. Dent. Res., April 1, 2006; 19(1): 99 - 105.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Engelmark, A. Beskow, J. Magnusson, H. Erlich, and U. Gyllensten
Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer
Hum. Mol. Genet., September 1, 2004; 13(17): 1951 - 1958.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S.-M. Huang and D. J. McCance
Down Regulation of the Interleukin-8 Promoter by Human Papillomavirus Type 16 E6 and E7 through Effects on CREB Binding Protein/p300 and P/CAF
J. Virol., July 29, 2002; 76(17): 8710 - 8721.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-J. Lee, Y.-S. Cho, M.-C. Cho, J.-H. Shim, K.-A. Lee, K.-K. Ko, Y. K. Choe, S.-N. Park, T. Hoshino, S. Kim, et al.
Both E6 and E7 Oncoproteins of Human Papillomavirus 16 Inhibit IL-18-Induced IFN-{{gamma}} Production in Human Peripheral Blood Mononuclear and NK Cells
J. Immunol., July 1, 2001; 167(1): 497 - 504.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
M. Scott, M. Nakagawa, and A.-B. Moscicki
Cell-Mediated Immune Response to Human Papillomavirus Infection
Clin. Vaccine Immunol., March 1, 2001; 8(2): 209 - 220.
[Full Text] [PDF]


Home page
Obstet GynecolHome page
J. R. GAGE, A. K. SANDHU, M. NIHIRA, M. D. G. BONECINI-ALMEIDA, P. CRISTOFORONI, T. KISHIMOTO, F. J. MONTZ, and O. MARTINEZ-MAZA
Effects of Human Papillomavirus-Associated Cells on Human Immunodeficiency Virus Gene Expression
Obstet. Gynecol., December 1, 2000; 96(6): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Liu, V. Tergaonkar, S. Krishna, and E. J. Androphy
Human Papillomavirus Type 16 E6-enhanced Susceptibility of L929 Cells to Tumor Necrosis Factor alpha Correlates with Increased Accumulation of Reactive Oxygen Species
J. Biol. Chem., August 27, 1999; 274(35): 24819 - 24827.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Tartour, F. Fossiez, I. Joyeux, A. Galinha, A. Gey, E. Claret, X. Sastre-Garau, J. Couturier, V. Mosseri, V. Vives, et al.
Interleukin 17, a T-cell-derived Cytokine, Promotes Tumorigenicity of Human Cervical Tumors in Nude Mice
Cancer Res., August 1, 1999; 59(15): 3698 - 3704.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Hubert, F. van den Brule, S. L. Giannini, E. Franzen-Detrooz, J. Boniver, and P. Delvenne
Colonization of in Vitro-Formed Cervical Human Papillomavirus-Associated (Pre)Neoplastic Lesions with Dendritic Cells : Role of Granulocyte/Macrophage Colony-Stimulating Factor
Am. J. Pathol., March 1, 1999; 154(3): 775 - 784.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. N. Fichorova and D. J. Anderson
Differential Expression of Immunobiological Mediators by Immortalized Human Cervical and Vaginal Epithelial Cells
Biol Reprod, February 1, 1999; 60(2): 508 - 514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.